General MedicationsINTRAVENOUSStandard
IVRA
MELPHALAN HYDROCHLORIDE
Standard Dose
EQ 90MG BASE/ML (EQ 90MG BASE/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview IVRA is listed in Drugs@FDA under application 217110 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient MELPHALAN HYDROCHLORIDE Form and strength SOLUTION;INTRAVENOUS - EQ 90MG BASE/ML (EQ 90MG BASE/ML) Sponsor APOTEX Submission history Latest submission status date: 2024-07-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview IVRA is listed in Drugs@FDA under application 217110 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MELPHALAN HYDROCHLORIDE Form and strength SOLUTION;INTRAVENOUS - EQ 90MG BASE/ML (EQ 90MG BASE/ML) Sponsor APOTEX Submission history Latest submission status date: 2024-07-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.